Since the Warburg effect is a common metabolic feature of cancer cells, understanding the structural basis of the CMTM6/Glut1 interaction may provide opportunities for the design of drugs that target the CMTM6/Glut1 interaction. This evidence concerns the gene SLC2A1 and cancer.